Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 1, 1998, Pages 86-93

  Schwarze, Jürgen ^a   Hamelmann, Eckard ^a   Cieslewicz, Grzegorz ^a   Tomkinson, Adrian ^a   Joetham, Anthony ^a   Bradley, Katherine ^a   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Adverse effects; Airway inflammation; Allergen; Body plethysmography; IL 12; Mice; Respiratory hypersensitivity

Indexed keywords

CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 5; RECOMBINANT INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY PLETHYSMOGRAPHY; BONE MARROW SUPPRESSION; BRONCHUS HYPERREACTIVITY; CELL INFILTRATION; CYTOKINE PRODUCTION; DOSE RESPONSE; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; INFLAMMATORY CELL; INTRANASAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; LOEFFLER PNEUMONIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SENSITIZATION; SPLEEN WEIGHT; SPLENOMEGALY;

EID: 0031817368     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70058-2     Document Type: Article

References (40)

1. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in branchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 1988;137:62-9.
2. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC Jr. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-15.
3. Robinson DS, Hamid Q, Ying A, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
4. + T cells in asthma. Immunol Cell Biol 1996;74:206-8.
5. + T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997;158:3539-44.
6. + T cells. J Exp Med 1993;177:573-6.
7. Lack G, Renz H, Saloga J, Bradley KL, Loader J, Leung DYM, et al. Nebulized but not parenteral IFN-γ decreases IgE production and normalizes airways function in a murine model of allergen sensitization. J Immunol 1994;152:2546-54.
8. Lack G, Bradley KL, Hamelmann E, Renz H, Loader J, Leung DYM, et al. Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J Immunol 1996;157:1432-9.
9. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170:827-46.
10. Stern AS, Podlaski FJ, Hulmes JD, Pan YE, Quinn PM, Wolitzky AG, et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 1990;87:6808-12.
11. D'Andrea A, Rengaraju M, Valiante NM, Chehmini J, Kubin M, Aste-Amezaga M, et al. Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells. J Exp Med 1992;176:1387-98.
12. Chan S, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, et al. Induction of IFN-γ production by NK cell stimulatory factor (NKSF): characterization of the responder cells and synergy with other inducers. J Exp Med 1991;173:869-79.
13. + T cells occurs through macrophage production of IL-12. Science 1993;260:547-9.
14. Manetti R, Parronchi P, Giudizi MG, Picinni M-P, Maggi E, Trinchieri G, et al. Natural killer cell stimulatory factor (NKSF/IL-12) induces Th-1 type specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med 1993;177:1199-204.
15. Morris SC, Madden KB, Adamovicz JJ, Gause WC, Hubbard BR, Gately MK, et al. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 1994;152:1047-56.
16. Kips JC, Brusselle GG, Joos GF, Peleman RA, Devos RR, Tavernier JH, et al.Importance of interleukin-4 and interleukin-12 in allergen-induced airway changes in mice. Int Arch Allergy Immunol 1995;107:115-8.
17. Sur S, Lam J, Bouchard P, Sigounas A, Holbert D, Metzger WJ. Immunomodularory effect of IL-12 on allergic lung inflammation depend on timing of doses. J Immunol 1996;157:4173-80.
18. Kips JC, Brusselle GG, Joos GF, Peleman RA, Tavernier JH, Devos RR, et al. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1996;153:535-9.
19. Iwamoto I, Kumano K, Masai M, Kurasawa K, Nakao A. Interleukin-12 prevents antigen-induced eosinophil recruitment into mouse airways. Am J Respir Crit Care Med 1996;154:1257-60.
20. Sarmiento UM, Riley JH, Knaack PA, Lipman JM, Decker JM, Gately MK, et al. Biologic effects of recombinant human interleukin-12 in squirrel monkeys (Sciureus saimiri). Lab Invest 1994;71:862-73.
21. Gately MK, Warrier RR, Honasoge S, Carvajal DM, Faherty DA, Connaughton SE, et al. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int Immunol 1994;6:157-67.
22. Eng VM, Car BD, Schnyder B, Lorenz M, Lugli S, Aguet M, et al. The stimulatory effects of interleukin (IL)-12 in hematopoiesis are antagonized by IL-12-induced interferon-γ in vivo. J Exp Med 1995;181:1893-8.
23. Car BD, Eng VM, Schnyder B, Le Hir M, Shakhov AN, Woerly G, et al. Role of interferon-γ in interleukin-12 induced pathology in mice. Am J Pathol 1995;147:1693-707.
24. Hendrzak JA, Brunda MJ. Biology of disease, IL-12, biological activity, therapeutic utility, and role in disease. Lab Invest 1995;72:619-37.
25. Bellone G, Trinchieri G. Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis. J Immunol 1994;153:930-7.
26. Hall SS. IL-12 at the crossroads [news]. Science 1995;268:1432-4.
27. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, et al. Nonivasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997;156:766-75.
28. Lavnikova N, Prokhorova S, Heylar L, Laskin DL. Isolation and partial characterization of subpopulations of alveolar macrophages, granulocytes and highly enriched interstitial macrophages from rat lung. Am J Respir Cell Mol Biol 1993;8:384-92.
29. Oshiba A, Hamelmann E, Takeda K, Bradley K, Loader JE, Larsen GL, et al. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J Clin Invest 1996;97:1398-408.
30. Hamelmann E, Oshiba A, Loader J, Larsen GL, Gleich G, Lee J, et al. Anti-interleukin 5 (IL-5) antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med 1997;155:819-25.
31. Schumacher JH, O'Garra A, Shrader B, van Kimmenade A, Bond MW, Mosmann TR, et al. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent assay. J Immunol 1988;141:1576-81.
32. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.
33. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelmann FD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:1527-36.
34. Asmundsson T, Johnson RF, Kilburn KH, Goodrich JK. Efficiency of nebulizers for depositing saline in human lung. Am Rev Respir Dis 1973;1089:506-12.
35. Finkelman FD, Holmes J. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990;8:303-33.
36. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996;183:109-17.
37. Garlisi CG, Falcone A, Kung TT, Stelts D, Pennline KJ, Beavis AJ, et al. T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin Immunol Immunopathol 1995;75:75-83.
38. Desai BB, Quinn PM, Wolitzki AG, Mongini PKA, Chizzonite R, Gately MK. IL-12 receptor. II. Distribution and regulation of receptor expression. J Immunol 1992;148:3125-32.
39. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, et al. A functional interleukin-12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci USA 1996;93:14002-7.
40. Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997;185:817-24.